Publications by authors named "Alan Stapleton"

Claim this Profile
P
Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens.
James G Kench, David R Clouston, Warick Delprado, Thomas Eade, David Ellis, Alan M F Stapleton

Pathology· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
Hayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, Anne Y Warren, Johanna Burge, Alan Stapleton

PLoS One· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome.
David F Callen, Carmela Ricciardelli, Miriam Butler, Alan Stapleton, Jurgen Stahl

Oncol Rep· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal PSA tests--delays in referral.
Alan M F Stapleton, Richard L Johns, Tina Kopsaftis, David J Tamblyn, Carole B Pinnock

Aust Fam Physician· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomograms for prostate cancer--is their use evidence-based?
Alan M F Stapleton, Carole B Pinnock

Nat Clin Pract Urol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
Paraskevi Tsoutsikos, John O Miners, Alan Stapleton, Anthony Thomas, Benedetta C Sallustio

Biochem Pharmacol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coping with prostate cancer: a quantitative analysis using a new instrument, the centre for clinical excellence in urological research coping with cancer instrument.
David I Ben-Tovim, Melissa L G Dougherty, Alan M F Stapleton, Carole B Pinnock

Urology· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis